| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.005 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.008 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |